Saha A, Whiting J, Mohty R, Flores K, et al. A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma. Bone Marrow Transplant 2026 Jul 17. doi: 10.1038/s41409-026-02936.
PMID: 42469394